Nika Pharmaceuticals NIKA Growth Metrics (2021-2023)

OTC NIKA
$0.42 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT
Growth Metrics Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023
Growth Ratios
Assets Growth (1y) (Quarter) 116.54%5,272.29%29.35%178.74%0.00%
Assets (QoQ) (Quarter) -79.20%10,195.18%-54.20%-77.93%416.09%147.88%-1.29%-92.08%
Cash & Equivalents Growth (1y) (Quarter) -93.88%130.37%116.54%5,272.29%178.74%0.00%
Cash & Equivalents (QoQ) (Quarter) -76.52%-79.20%-77.93%416.09%147.88%-1.29%-92.08%
Cash from Operations Growth (1y) (Quarter) -9.77%679.32%390.44%-42.39%-209.85%290.54%29.39%
Cash from Operations (QoQ) (Quarter) 48.57%8.79%1,067.91%-124.18%371.41%-54.27%91.99%-230.03%442.08%-84.85%
EBIT Growth (1y) (Quarter) 209.77%-106,557.99%-134.86%-356.06%209.85%99.12%-60.01%
EBIT (QoQ) (Quarter) 48.57%8.79%-22.27%291.39%-50,068.49%99.80%-137.42%230.03%-242.08%63.52%
EBT Growth (1y) (Quarter) 209.77%-106,757.99%-334.86%42.39%-409.85%99.12%-60.01%
EBT (QoQ) (Quarter) 151.43%-8.79%-1,067.91%124.18%-50,068.49%99.80%-137.42%-30.03%-42.08%63.52%
Enterprise Value Growth (1y) (Quarter) 93.88%-130.37%-116.54%-5,272.29%-178.74%0.00%
Enterprise Value (QoQ) (Quarter) 76.52%79.20%77.93%-416.09%-147.88%1.29%92.08%
EPS (Basic) Growth (1y) (Quarter) 209.77%-2,001.45%-104.19%98.95%-104.67%99.26%-35.26%
EPS (Basic) (QoQ) (Quarter) 151.43%-8.79%-1,067.91%124.18%-990.82%99.80%-142.88%-7.45%-42.08%63.52%
EPS (Diluted) Growth (1y) (Quarter) 209.77%-57,143.51%-225.61%68.48%-104.67%99.26%-35.26%
EPS (Diluted) (QoQ) (Quarter) 101.71%-8.79%-1,067.91%825.31%-990.82%99.80%-142.88%-7.45%-42.08%63.52%
Free Cash Flow Growth (1y) (Quarter) -9.77%679.32%390.44%-42.39%-209.85%290.54%29.39%
Free Cash Flow (QoQ) (Quarter) 48.57%8.79%1,067.91%-124.18%371.41%-54.27%91.99%-230.03%442.08%-84.85%
Interest Coverage Ratio Growth (1y) (Quarter) 79.24%
Net Cash Flow Growth (1y) (Quarter) -24.41%3,240.15%749.12%-3.82%1,237.66%236.54%82.34%
Net Cash Flow (QoQ) (Quarter) -277.56%235.66%2,061.72%-101.12%9,629.75%-63.32%144.86%-86.71%2,719.08%-80.12%
Net Income Growth (1y) (Quarter) 209.77%-106,757.99%-334.86%42.39%-409.85%99.12%-60.01%
Net Income (QoQ) (Quarter) 151.43%-8.79%-1,067.91%124.18%-50,068.49%99.80%-137.42%-30.03%-42.08%63.52%
Net Income towards Common Stockholders Growth (1y) (Quarter) 209.77%-106,757.99%-334.86%42.39%-409.85%99.12%-60.01%
Net Income towards Common Stockholders (QoQ) (Quarter) 151.43%-8.79%-1,067.91%124.18%-50,068.49%99.80%-137.42%-30.03%-42.08%63.52%
Operating Income Growth (1y) (Quarter) 209.77%-106,557.99%-134.86%-356.06%209.85%99.12%-60.01%
Operating Income (QoQ) (Quarter) 48.57%8.79%-22.27%291.39%-50,068.49%99.80%-137.42%230.03%-242.08%63.52%
Profit After Tax Growth (1y) (Quarter) -209.77%-106,757.99%-334.86%42.39%-209.85%99.12%-60.01%
Profit After Tax (QoQ) (Quarter) -48.57%-8.79%-1,067.91%75.82%-49,868.49%99.80%-137.42%-30.03%-42.08%63.52%
Return on Assets Growth (1y) (Quarter) -0.00M727.00504.000.00M
Return on Assets (QoQ) (Quarter) -677.00225.00-817.00126.000.00M2.00-3.00
Return on Capital Employed Growth (1y) (Quarter) -199.72M638.25M
Return on Capital Employed (QoQ) (Quarter) -837.98M640.26M-1.19M-0.81M114.00
Total Debt Growth (1y) (Quarter) -24.31%2,448.62%1,287.46%0.00%
Total Debt (QoQ) (Quarter) 107.94%194.17%127.42%83.20%13.20%-78.80%